VYNE Therapeutics (VYNE) Inventory (2019 - 2021)

VYNE Therapeutics' Inventory history runs 3 years deep, the most recent figure standing at $7.3 million for Q4 2021.

• Quarterly Inventory fell 1.53% year-over-year to $7.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $7.3 million (down 1.53% YoY) and the FY2021 annual result came in at $7.3 million, down 1.53% from the prior year.
• Inventory was $7.3 million for Q4 2021 at VYNE Therapeutics, down from $8.1 million in the prior quarter.
• Across five years, Inventory topped out at $8.3 million in Q2 2021 and bottomed at $1.4 million in Q4 2019.
• A 3-year average of $6.2 million and a median of $7.3 million in 2021 frame the typical range for Inventory.
• Annual changes were most pronounced in 2020 — Inventory surged 446.02% — and 2021, when it declined 1.53%.
• VYNE Therapeutics' Inventory stood at $1.4 million in 2019, then jumped by 446.02% to $7.4 million in 2020, then slipped by 1.53% to $7.3 million in 2021.
• Business Quant data shows VYNE's Inventory at $7.3 million in Q4 2021, $8.1 million in Q3 2021, and $8.3 million in Q2 2021.